Three rheumatoid arthritis comparisons found no significant improvement
Comparison in people · 1984
- What was studied
- Three rheumatoid arthritis studies. The indexed abstract omits enrollment and arm sizes.
- Main finding
- Clinical response across the three studies · None of the three studies found statistically significant clinical improvement. Most patients failed to improve or dropped out for lack of effect.
Reported findings and study design
Reported findings
A six-month double-blind placebo comparison of three subcutaneous doses, a long-term open subcutaneous study, and a three-week double-blind study of 100 mg/day intravenously. The abstract does not list the subcutaneous dose levels.
Population or model Three rheumatoid arthritis studies. The indexed abstract omits enrollment and arm sizes.
Dose, route and schedule
A six-month double-blind placebo comparison of three subcutaneous doses, a long-term open subcutaneous study, and a three-week double-blind study of 100 mg/day intravenously. The abstract does not list the subcutaneous dose levels.
Protocol source ↗ · Original indexed abstract of a three-study report.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Clinical response across the three studies | None of the three studies found statistically significant clinical improvement. Most patients failed to improve or dropped out for lack of effect. | |
| Reported safety | The authors reported no serious side effects. |
The available abstract gives no arm-level outcome values or counts. Its protocols differ from the weekly injection comparisons in Veys’s 1982 paper, and no cross-trial participant total is available.
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- The available abstract gives no arm-level outcome values or counts. Its protocols differ from the weekly injection comparisons in Veys’s 1982 paper, and no cross-trial participant total is available.
Source details
Original indexed abstract of a three-study report.
Sources checked
Added to the library
Citation
E. M. Veys, H. Mielants, G. Verbruggen, T. Spiro, E. Newdeck, D. Power, G. Goldstein. Three rheumatoid arthritis comparisons found no significant improvement Journal of Rheumatology 11(4), 462–466